Following breast cancer removal by lumpectomy, whole breast irradiation is commonly required. We know that when breast cancer cells return after surgical removal, they often recur in the area where the tumor was removed.
Women with a strong family history of breast and ovarian cancer have an increased risk of developing these diseases. Sometimes this strong family history indicates a BRCA1 or BRCA2 gene mutation, making the odds of developing these cancers even higher.
Stephen Edge, MD, formerly of RPCI and Alfiero Foundation Endowed Chair in Breast Oncology, and Gokul Das, PhD, Co-Director of RPCI's Breast Disease Site Research Group joined Roswellness Radio this past Sunday.